Neurotransmitter changes after traumatic brain injury: an update for new treatment strategies (Q57157638)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30214042%20AND%20SRC:MED&resulttype=core&format=json

22 April 2020

title

Neurotransmitter changes after traumatic brain injury: an update for new treatment strategies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30214042%20AND%20SRC:MED&resulttype=core&format=json

22 April 2020

1 reference

Robert E McCullumsmith

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30214042%20AND%20SRC:MED&resulttype=core&format=json

22 April 2020

language of work or name

English

0 references

publication date

13 September 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30214042%20AND%20SRC:MED&resulttype=core&format=json

22 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30214042%20AND%20SRC:MED&resulttype=core&format=json

22 April 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30214042%20AND%20SRC:MED&resulttype=core&format=json

22 April 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30214042%20AND%20SRC:MED&resulttype=core&format=json

22 April 2020

page(s)

995-1012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30214042%20AND%20SRC:MED&resulttype=core&format=json

Changing patterns in the epidemiology of traumatic brain injury

22 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Post-acute traumatic brain injury rehabilitation: effects on outcome measures and life care costs

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Antibody against early driver of neurodegeneration cis P-tau blocks brain injury and tauopathy

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Spreading depolarizations and late secondary insults after traumatic brain injury

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Imipramine treatment improves cognitive outcome associated with enhanced hippocampal neurogenesis after traumatic brain injury in mice

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Implantation of Neuronal Stem Cells Enhances Object Recognition without Increasing Neurogenesis after Lateral Fluid Percussion Injury in Mice.

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Acute minocycline treatment mitigates the symptoms of mild blast-induced traumatic brain injury

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Evaluation of late cognitive impairment and anxiety states following traumatic brain injury in mice: the effect of minocycline.

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Lactate storm marks cerebral metabolism following brain trauma

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Glutamate Neurotransmission in Rodent Models of Traumatic Brain Injury.

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Placebo-controlled trial of amantadine for severe traumatic brain injury

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Results of phase 2 safety and feasibility study of treatment with levetiracetam for prevention of posttraumatic epilepsy.

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Prospective, randomized, single-blinded comparative trial of intravenous levetiracetam versus phenytoin for seizure prophylaxis

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Armodafinil for the treatment of excessive sleepiness associated with mild or moderate closed traumatic brain injury: a 12-week, randomized, double-blind study followed by a 12-month open-label extension

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Sertraline for Preventing Mood Disorders Following Traumatic Brain Injury: A Randomized Clinical Trial.

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Diagnosis and management of acute concussion

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

The Glasgow Coma Scale at 40 years: standing the test of time

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Classification of traumatic brain injury for targeted therapies

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Cellular and subcellular change evoked by diffuse traumatic brain injury: a complex web of change extending far beyond focal damage

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

The Molecular Pathophysiology of Concussive Brain Injury - an Update

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

The neurophysiology of brain injury

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Long-Term Consequences of Traumatic Brain Injury: Current Status of Potential Mechanisms of Injury and Neurological Outcomes

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Selected cases of poor outcome following a minor brain trauma: comparing neuropsychological and positron emission tomography assessment

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Epigenetic changes following traumatic brain injury and their implications for outcome, recovery and therapy

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Systematic bias in traumatic brain injury outcome studies because of loss to follow-up.

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Animal models of traumatic brain injury

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Challenges in the development of rodent models of mild traumatic brain injury

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Attack and defense in rodents as ethoexperimental models for the study of emotion

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Symptom complaints following reports of blast versus non-blast mild TBI: does mechanism of injury matter?

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

In vitro models of traumatic brain injury

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

How inhibition shapes cortical activity

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Environmental enrichment and the sensory brain: the role of enrichment in remediating brain injury.

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Theoretical basis for brain plasticity after a TBI.

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Speed of processing and strategic control of attention after traumatic brain injury

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Validating Multidimensional Outcome Assessment Using the TBI Common Data Elements: An Analysis of the TRACK-TBI Pilot Sample.

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Cognitive functioning ten years following traumatic brain injury and rehabilitation

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Psychiatric disorders following traumatic brain injury: their nature and frequency

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Association of traumatic brain injury with subsequent neurological and psychiatric disease: a meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Neuropsychiatric problems after traumatic brain injury: unraveling the silent epidemic

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Association between cognitive impairments and anxiety disorders following traumatic brain injury.

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Depression following adult, non-penetrating traumatic brain injury: a meta-analysis examining methodological variables and sample characteristics

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Understanding the pathophysiology of depression: From monoamines to the neurogenesis hypothesis model - are we there yet?

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Role of Neuro-Immunological Factors in the Pathophysiology of Mood Disorders: Implications for Novel Therapeutics for Treatment Resistant Depression

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

The role of glutamate transporters in the pathophysiology of neuropsychiatric disorders

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Long-term potentiation and contextual fear conditioning increase neuronal glutamate uptake.

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Massive increases in extracellular potassium and the indiscriminate release of glutamate following concussive brain injury

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

The role of excitatory amino acids and NMDA receptors in traumatic brain injury

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Control of Glutamate Transport by Extracellular Potassium: Basis for a Negative Feedback on Synaptic Transmission

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Traumatic Brain Injury Induces Alterations in Cortical Glutamate Uptake without a Reduction in Glutamate Transporter-1 Protein Expression

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Excitotoxicity and Metabolic Crisis Are Associated with Spreading Depolarizations in Severe Traumatic Brain Injury Patients

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Cortical spreading depression in traumatic brain injuries: is there a role for astrocytes?

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Spreading depolarization monitoring in neurocritical care of acute brain injury.

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Novel approach to the role of NMDA receptors in traumatic brain injury

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Neurometabolic changes in the acute phase after sports concussions correlate with symptom severity

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Dynamic changes in N-methyl-D-aspartate receptors after closed head injury in mice: Implications for treatment of neurological and cognitive deficits

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Excitatory amino acid receptor subtype binding following traumatic brain injury

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Ex Vivo Tracing of NMDA and GABA-A Receptors in Rat Brain After Traumatic Brain Injury Using 18F-GE-179 and 18F-GE-194 Autoradiography

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Alterations of GABA(A) and glutamate receptor subunits and heat shock protein in rat hippocampus following traumatic brain injury and in posttraumatic epilepsy

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Calcium-permeable AMPA receptors appear in cortical neurons after traumatic mechanical injury and contribute to neuronal fate

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Early loss of the glutamate transporter splice-variant GLT-1v in rat cerebral cortex following lateral fluid-percussion injury

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Glutamate transporter EAAT4 is increased in hippocampal astrocytes following lateral fluid-percussion injury in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Early expression of glutamate transporter proteins in ramified microglia after controlled cortical impact injury in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Decreased expression of glutamate transporters in astrocytes after human traumatic brain injury

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Clinical trials in traumatic brain injury: past experience and current developments.

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury?

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Glutamate-based therapeutic approaches: clinical trials with NMDA antagonists

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Magnesium sulfate for neuroprotection after traumatic brain injury: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Neuronal death enhanced by N-methyl-D-aspartate antagonists

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Modulation of Synaptic Plasticity in the Cortex Needs to Understand All the Players

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Homeostatic competition between phasic and tonic inhibition

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

γ-Aminobutyric acid type A (GABAA) receptor α subunits play a direct role in synaptic versus extrasynaptic targeting

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Glutamate and GABA imbalance following traumatic brain injury

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

GABA(A) receptor regulation after experimental traumatic brain injury

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Changes in mACh, NMDA and GABA(A) receptor binding after lateral fluid-percussion injury: in vitro autoradiography of rat brain frozen sections

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Enduring suppression of hippocampal long-term potentiation following traumatic brain injury in rat

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Impaired expression of long-term potentiation in hippocampal slices 4 and 48 h following mild fluid-percussion brain injury in vivo

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Long-term potentiation deficits and excitability changes following traumatic brain injury

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Behavioral, electrophysiological, and histopathological consequences of mild fluid-percussion injury in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Brain Injury Impairs Working Memory and Prefrontal Circuit Function

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Transition from Initial Hypoactivity to Hyperactivity in Cortical Layer V Pyramidal Neurons after Traumatic Brain Injury In Vivo

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Regional hippocampal alteration associated with cognitive deficit following experimental brain injury: a systems, network and cellular evaluation

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Mechanisms underlying the inability to induce area CA1 LTP in the mouse after traumatic brain injury

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Reduced GABAergic inhibition in the basolateral amygdala and the development of anxiety-like behaviors after mild traumatic brain injury.

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Persistent working memory dysfunction following traumatic brain injury: evidence for a time-dependent mechanism

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Hypo-excitation across all cortical laminae defines intermediate stages of cortical neuronal dysfunction in diffuse traumatic brain injury

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Progressive loss of phasic, but not tonic, GABAA receptor-mediated inhibition in dentate granule cells in a model of post-traumatic epilepsy in rats

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Enduring changes in tonic GABAA receptor signaling in dentate granule cells after controlled cortical impact brain injury in mice

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Increase of GABAA receptor-mediated tonic inhibition in dentate granule cells after traumatic brain injury

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Synaptic reorganization of inhibitory hilar interneuron circuitry after traumatic brain injury in mice

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Traumatic Brain Injury Increases Cortical Glutamate Network Activity by Compromising GABAergic Control

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Chronic failure in the maintenance of long-term potentiation following fluid percussion injury in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Genetic variation in neuronal glutamate transport genes and associations with posttraumatic seizure.

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Effectiveness of amantadine hydrochloride in the reduction of chronic traumatic brain injury irritability and aggression

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Amantadine Effect on Perceptions of Irritability after Traumatic Brain Injury: Results of the Amantadine Irritability Multisite Study

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Pharmacotherapy for chronic cognitive impairment in traumatic brain injury

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Amantadine for patients with severe traumatic brain injury: a critically appraised topic

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Memantine preferentially blocks extrasynaptic over synaptic NMDA receptor currents in hippocampal autapses

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Paradigm shift in neuroprotection by NMDA receptor blockade: Memantine and beyond

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Dual-transmitter systems regulating arousal, attention, learning and memory.

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Neuromodulatory transmitter systems in the cortex and their role in cortical plasticity

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Prefrontal acetylcholine release controls cue detection on multiple timescales

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Alterations in Cholinergic Pathways and Therapeutic Strategies Targeting Cholinergic System after Traumatic Brain Injury

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Cholinergic dysfunction after traumatic brain injury: preliminary findings from a PET study.

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Time-dependent alterations of cholinergic markers after experimental traumatic brain injury

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Reduced evoked release of acetylcholine in the rodent hippocampus following traumatic brain injury

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Post-injury administration of BIBN 99, a selective muscarinic M2 receptor antagonist, improves cognitive performance following traumatic brain injury in rats

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Activating the posttraumatic cholinergic system for the treatment of cognitive impairment following traumatic brain injury

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Effects of CDP-choline treatment on neurobehavioral deficits after TBI and on hippocampal and neocortical acetylcholine release

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Cholinergic augmentation with donepezil enhances recovery in short-term memory and sustained attention after traumatic brain injury

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Central acetylcholinesterase inhibitors in the treatment of chronic traumatic brain injury-clinical experience in 111 patients

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Effects of rivastigmine on cognitive function in patients with traumatic brain injury

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Brain Cholinergic Function and Response to Rivastigmine in Patients With Chronic Sequels of Traumatic Brain Injury: A PET Study

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Catecholamines and cognition after traumatic brain injury

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Role of locus coeruleus in attention and behavioral flexibility

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Focal traumatic brain injury causes widespread reductions in rat brain norepinephrine turnover from 6 to 24 h

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

The morphological and neurochemical effects of diffuse brain injury on rat central noradrenergic system

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Widespread and lateralization effects of acute traumatic brain injury on norepinephrine turnover in the rat brain.

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Decreased alpha 1-adrenergic receptors after experimental brain injury

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Complexity of dopamine metabolism.

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Traumatic brain injury in adult rats causes progressive nigrostriatal dopaminergic cell loss and enhanced vulnerability to the pesticide paraquat

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Substantia nigra vulnerability after a single moderate diffuse brain injury in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Time dependent alterations in dopamine tissue levels and metabolism after experimental traumatic brain injury in rats

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Enhanced catecholamine synthesis in the prefrontal cortex after traumatic brain injury: implications for prefrontal dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Amantadine ameliorates dopamine-releasing deficits and behavioral deficits in rats after fluid percussion injury

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Controlled cortical impact injury affects dopaminergic transmission in the rat striatum

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

The influence of genetic variants on striatal dopamine transporter and D2 receptor binding after TBI.

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

The effects of bromocriptine on attention deficits after traumatic brain injury: a placebo-controlled pilot study.

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Use of methylphenidate in traumatic brain injury

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Methylphenidate treatment of attention-deficit/hyperactivity disorder secondary to traumatic brain injury: a critical appraisal of treatment studies

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

A current view of serotonin transporters

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Traumatic brain injury decreases serotonin transporter expression in the rat cerebrum

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Fluoxetine increases hippocampal neurogenesis and induces epigenetic factors but does not improve functional recovery after traumatic brain injury

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Selective Serotonin Reuptake Inhibitors for Treating Neurocognitive and Neuropsychiatric Disorders Following Traumatic Brain Injury: An Evaluation of Current Evidence

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Impact of early administration of sertraline on depressive symptoms in the first year after traumatic brain injury

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

A randomized controlled trial of sertraline for the treatment of depression in persons with traumatic brain injury

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

A randomized controlled trial of antidepressant continuation for major depression following traumatic brain injury

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Impact of early administration of sertraline on cognitive and behavioral recovery in the first year after moderate to severe traumatic brain injury.

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Sertraline for Major Depression During the Year Following Traumatic Brain Injury: A Randomized Controlled Trial

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Adenosine neuromodulation and traumatic brain injury

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Purinergic receptors in psychiatric disorders

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Adenosine receptor neurobiology: overview.

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Neuroglial Transmission

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Astrocytic purinergic signaling coordinates synaptic networks

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Hippocampal GABAergic transmission: a new target for adenosine control of excitability

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Adenosine A2A receptors modulate glutamate uptake in cultured astrocytes and gliosomes.

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Local glutamate level dictates adenosine A2A receptor regulation of neuroinflammation and traumatic brain injury

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Interstitial adenosine, inosine, and hypoxanthine are increased after experimental traumatic brain injury in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Adenosine A1 receptor knockout mice develop lethal status epilepticus after experimental traumatic brain injury

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Adenosine A2A receptor deficiency alleviates blast-induced cognitive dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Genetic variation in the adenosine regulatory cycle is associated with posttraumatic epilepsy development

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Adenosine A1 receptor gene variants associated with post-traumatic seizures after severe TBI.

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Genetic biomarkers of posttraumatic epilepsy: A systematic review

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Plasticity of cortical excitatory-inhibitory balance.

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Persistent cognitive dysfunction after traumatic brain injury: A dopamine hypothesis

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Plasticity in the Working Memory System: Life Span Changes and Response to Injury

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

The noradrenaline transporter as site of action for the anti-Parkinson drug amantadine.

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Possible use of amantadine in depression

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

α2 Adrenergic Receptor Trafficking as a Therapeutic Target in Antidepressant Drug Action

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Therapeutic targeting of the pathological triad of extrasynaptic NMDA receptor signaling in neurodegenerations.

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Main path and byways: non-vesicular glutamate release by system xc(-) as an important modifier of glutamatergic neurotransmission

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Regulation of hippocampal synaptic strength by glial xCT.

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Is L-lactate a novel signaling molecule in the brain?

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Is lactate a volume transmitter of metabolic states of the brain?

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Lactate receptor sites link neurotransmission, neurovascular coupling, and brain energy metabolism.

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Lactate modulates the activity of primary cortical neurons through a receptor-mediated pathway

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Cerebral extracellular lactate increase is predominantly nonischemic in patients with severe traumatic brain injury

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Glycolysis and the significance of lactate in traumatic brain injury

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Half-molar sodium lactate infusion to prevent intracranial hypertensive episodes in severe traumatic brain injured patients: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Changes in the neurochemistry of athletes with repetitive brain trauma: preliminary results using localized correlated spectroscopy

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Myoinositol and glutamate complex neurometabolite abnormality after mild traumatic brain injury.

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Neurometabolite concentrations in gray and white matter in mild traumatic brain injury: an 1H-magnetic resonance spectroscopy study

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

A Longitudinal Proton Magnetic Resonance Spectroscopy Study of Mild Traumatic Brain Injury

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Focal neuronal damage in patients with neuropsychological impairment after diffuse traumatic brain injury: evaluation using ¹¹C-flumazenil positron emission tomography with statistical image analysis

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Effects of the dopaminergic agent and NMDA receptor antagonist amantadine on cognitive function, cerebral glucose metabolism and D2 receptor availability in chronic traumatic brain injury: a study using positron emission tomography (PET).

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Therapies negating neuroinflammation after brain trauma

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Endocannabinoids: A Promising Impact for Traumatic Brain Injury.

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Cellular and molecular mechanisms of injury and spontaneous recovery

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Randomized controlled trials in adult traumatic brain injury: a review of compliance to CONSORT statement

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Re-orientation of clinical research in traumatic brain injury: report of an international workshop on comparative effectiveness research

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Toward an international initiative for traumatic brain injury research

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Traumatic brain injury: an international knowledge-based approach

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Transforming research and clinical knowledge in traumatic brain injury pilot: multicenter implementation of the common data elements for traumatic brain injury.

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI): a prospective longitudinal observational study

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

Genetic data sharing and privacy

1 reference

https://api.crossref.org/works/10.1038%2FS41380-018-0239-6

7 January 2021

10.1038/S41380-018-0239-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30214042%20AND%20SRC:MED&resulttype=core&format=json

22 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30214042%20AND%20SRC:MED&resulttype=core&format=json